Abiraterone

Abiraterone is a medication used in the treatment of advanced prostate cancer. It belongs to a class of drugs known as androgen synthesis inhibitors.

Abiraterone works by blocking the production of androgens, which are hormones that can fuel the growth of prostate cancer cells. By inhibiting androgen synthesis, abiraterone helps to slow down the progression of prostate cancer and improve patient outcomes.

The medication is typically prescribed in combination with other treatments, such as hormone therapy, and is often used in patients who have already received prior treatment for prostate cancer.

Common side effects of abiraterone may include fatigue, joint pain, high blood pressure, fluid retention, and liver function abnormalities. Regular monitoring of blood pressure, liver function, and other parameters may be necessary during treatment.

Abiraterone should only be used under the supervision and prescription of a qualified healthcare professional. The dosage and duration of treatment depend on individual factors, such as the stage of prostate cancer and the patient’s overall health.

In summary, abiraterone is a medication used in the treatment of advanced prostate cancer. It blocks the production of androgens to slow down the progression of the disease. Regular monitoring and adherence to healthcare provider instructions are important for successful treatment outcomes.